)
Visual
earnings real time
Syngene International (SYNGENE) investor relations material
Syngene International Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status Update summary17 Dec, 2025
Market overview and growth drivers
Global clinical research market is valued at $100 billion, growing at 11% CAGR, with the clinical CRO segment forming about 30% of the total market.
India’s clinical CRO market is projected to grow at 16% CAGR (2024–28), outpacing global rates due to large, diverse patient pools, cost advantages, and regulatory improvements.
APAC leads growth in clinical CROs, with India benefiting from a reliable regulatory environment, skilled workforce, and supportive geopolitical dynamics.
Key growth drivers include increased R&D pipelines, outsourcing acceleration, demand for diverse patient recruitment, and the rise of virtual biotech companies.
Major global CROs dominate, but Indian players like Syngene are gaining ground through local expertise and end-to-end service offerings.
Industry structure and competitive landscape
The Indian clinical CRO market is fragmented, with success factors including regulatory expertise, full-service offerings, and advanced digital/data capabilities.
Differentiated players with strong regulatory data management and comprehensive solutions have a competitive edge.
Key global and Indian players include IQVIA, ICON, Syneos, Lambda, Veeda, and Syngene.
Syngene's translational and clinical research capabilities
Syngene offers integrated, end-to-end clinical trial services, including protocol development, execution, data management, and reporting.
The company has expanded its team from 35-40 to over 200 employees, supporting larger and more complex trials.
Infrastructure includes 190 clinical beds, a network of 180 hospitals, and access to over 200 investigators across key therapeutic areas.
Syngene leverages AI and advanced bioanalytical platforms, with global accreditations and a strong track record in bioanalytical studies.
The business leverages a global clinical network, state-of-the-art infrastructure, and digital/AI-driven platforms for efficiency and compliance.
T&CR strategy for new modalities and phases?
How do operating models optimize global trials?
Dr. Kammili's impact on T&CR strategic focus?
Impact of new NDCT rules on trial timelines
Translational research: how does it accelerate drug entry?
Manpower needs for scaling clinical trials
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Syngene International earnings date
Q3 25/2622 Jan, 2026
Next Syngene International earnings date
Q3 25/2622 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Syngene International Ltd engages in the provision of contract research and manufacturing services to the pharmaceutical, nutrition, and plant biology industries. It offers a comprehensive range of services from discovery support to manufacture of life-enabling therapies.
The company is involved in three principal activities: providing drug discovery research services; drug development services; and manufacture of active pharmaceutical ingredients & Intermediates, Recombinant proteins, Bioagrochemicals, Biosimilars & Biogenerics and also offering third party research & manufacturing services, including custom synthesis projects. The company was incorporated in 1993 and is headquartered in Bengaluru, India.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage